Preventing Prescription Drug Problems: A Pilot Military Opioid Safety Initiative
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Brandeis University
- Enrollment
- 93
- Locations
- 2
- Primary Endpoint
- Use of SCRIPTS
Study Overview
Brief Summary
Brandeis University and University of South Carolina (USC) have joined together to develop the South Carolina Opioid Safety Initiative - Military (SCOSI-M), to develop an academic detailing (medical education) intervention for physicians and evaluate its effectiveness in a pilot study. The goal of the intervention is to increase the use of safe prescribing and prescription monitoring practices among primary care physicians. The research team will design and pilot an educational intervention for physicians who treat military personnel, veterans, and their families with prescription opioids. The overall aim of SCOSI-M is to prevent the onset or progression of prescription drug problems among Iraq and Afghanistan veterans, military members, and their families who are at high risk for developing problems if their treatment involves long-term use of an opioid.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 85 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •a physician within one of the 3 practice environments;
- •typically prescribes Schedule II opioids to 10 or more non-cancer pain patients each month;
- •if community office-based, a substantial number of patients must have TRICARE (e.g., 20%); and d) willing to provide written consent for data collection and release of own SCRIPTS data.
Exclusion Criteria
- •non-physician providers who report data to the SCRIPTS (dentist, veterinarians, nurses),
- •surgeons, pediatricians, or physicians predominately treating pain in cancer or surgical patients, and,
- •not eligible to register as authorized SCRIPTS user.
Outcomes
Primary Outcomes
Use of SCRIPTS
Time Frame: Up to 12 months
Primary outcomes, or effectiveness, will be measured first by the use of SCRIPTS when prescribing opioids (e.g., % of new patients the physician queried; % of patients with long-term use the physician queried).
Secondary Outcomes
No secondary outcomes reported